PMC:7074424 / 671-1070 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"14","span":{"begin":62,"end":70},"obj":"Gene"}],"attributes":[{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"Gene:164045"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterre"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T17","span":{"begin":12,"end":32},"obj":"PG_4"},{"id":"T16","span":{"begin":82,"end":86},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T15","span":{"begin":201,"end":205},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T14","span":{"begin":298,"end":302},"obj":"CHEBI:23888;CHEBI:23888"}],"text":", protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterre"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":25,"end":32},"obj":"Body_part"},{"id":"T5","span":{"begin":146,"end":154},"obj":"Body_part"},{"id":"T6","span":{"begin":247,"end":255},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":", protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterre"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":384,"end":385},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":", protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterre"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8","span":{"begin":25,"end":32},"obj":"Chemical"},{"id":"T9","span":{"begin":82,"end":86},"obj":"Chemical"},{"id":"T10","span":{"begin":146,"end":154},"obj":"Chemical"},{"id":"T11","span":{"begin":201,"end":205},"obj":"Chemical"},{"id":"T12","span":{"begin":247,"end":255},"obj":"Chemical"},{"id":"T13","span":{"begin":298,"end":302},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":", protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterre"}

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":113,"end":225},"obj":"Sentence"},{"id":"T10","span":{"begin":226,"end":323},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":", protease, nucleocapsid protein, hemagglutinin esterase, and helicase) for which drug design can be considered. There are other 16 nonstructural proteins (NSPs), which can also be considered from the drug design perspective. The major structural proteins and NSPs may serve an important role from drug design perspectives. However, the occurrence of frequent recombination events is a major deterre"}